Lexeo Therapeutics, Inc.

US$2.89As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LXEOHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (39.59%)
Div yield —
ROE (46.76%)
Biotechnology
Beta (5Y) 1.65
PE TTM —
TSR TTM (71.13%)
Mkt cap US$237.1M
ROIC (30.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.24
12.14%
(20.63%)
Hold 10|9|10|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
9.63%
5.05%
9.14%
6.89%
Revenue$M
28.20
27.95
28.34
29.95
9.51%
2.47%
1.58%
4.45%
Peers (US$237.1M)
Cap (US$)
PE
241.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.772
(0.095)
(0.092)
EBIT/Intx
1.249
0.636
0.442
Own earn%
(17.28)
(134.56)
(91.78)
Sh yield%
13.10
51.75
47.07
Owners
Insiders/Inst%
12.43
56.46
Short interest%
4.39
SBC / revenue%
5.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
19–27
$1 testx
—
Incr. ROIC%
24